CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,057 enrolled
Drug / intervention
Interviewer and tablet administration of the TAPS Toolother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02110693
NCT02110693N/ACompleted
CompareCT.gov

The TAPS Tool: Screen and Brief Assessment Tool Validation Study

Friends Research Institute, Inc.·interventional·Posted Apr 10, 2014·Updated Jul 26, 2018

In Brief

A clinical study evaluating Interviewer and tablet administration of the TAPS Tool for Substance Use Disorder. Completed, enrolled 2,057 participants across 4 sites.

Detailed Summary

The purpose of the study is to develop and validate a questionnaire to screen and assess adult primary care patients for tobacco, alcohol, prescription drug, and drug use and problems related to their use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubstance Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA), Johns Hopkins University, Virginia Commonwealth University, NYU Langone Health, Duke University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 10, 2014
Enrollment StartMar 1, 2014
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.2 years ago

Interventions

Interviewer and tablet administration of the TAPS Toolother

All participant will self-administer substance use screening instrument (TAPS Tool) on a tablet computer and will be administered the TAPS Tool by an interviewer.